Cargando…
COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Xenobiotics)
SARS-CoV-2 emerged in 2019 and led to the COVID-19 pandemic. Efforts to develop therapeutics against SARS-Cov-2 led to both new treatments and attempts to repurpose existing medications. Here, we provide a narrative review of the xenobiotics and alternative remedies used or proposed to treat COVID-1...
Autores principales: | Chary, Michael A., Barbuto, Alexander F., Izadmehr, Sudeh, Tarsillo, Marc, Fleischer, Eduardo, Burns, Michele M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756926/ https://www.ncbi.nlm.nih.gov/pubmed/36525217 http://dx.doi.org/10.1007/s13181-022-00918-y |
Ejemplares similares
-
COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Vaccines, Monoclonal Antibodies, and Immunotherapeutics)
por: Chary, Michael, et al.
Publicado: (2023) -
COVID-19: Therapeutics and Their Toxicities
por: Chary, Michael A., et al.
Publicado: (2020) -
Mechanisms of Osteoblastic Bone Metastasis in Prostate Cancer: Role of Prostatic Acid Phosphatase
por: Quiroz-Munoz, Mariana, et al.
Publicado: (2019) -
SUN-143 Prostatic Acid Phosphatase Is Not Regulated by Androgens During Prostate Development and Tumorigenesis
por: Izadmehr, Sudeh, et al.
Publicado: (2020) -
Prostatic Acid Phosphatase Is a Progenitor Cell Marker That Persists After Androgen Ablation
por: Izadmehr, Sudeh, et al.
Publicado: (2021)